• Home
  • Contact Us
  • Français
  • About Us
    • Vision
    • Who We Are
    • Why Choose King
    • Strategy
    • Fast Facts
  • |
  • Products
    • EpiPen.ca
    • Cytomel
  • |
  • Newsroom
    • FAQs
  • |
  • Business Development

News

It’s Life and Death: Canadian Actress Speaks Out About Living with Severe Allergies

EpiPen® Partners with Lucy Waverman, Canadian Culinary Personality,
to Offer Fresh, Natural Recipes for People Who Suffer from Life-Threatening Allergies

New Study Shows Most Canadians Not Prepared for Potentially Fatal Allergic Reactions

Montréal Broadcaster Normand Brathwaite Advises Quebeckers to Prepare for Allergy Season

King Pharmaceuticals Canada Launches EpiPen® Expiration Reminder

King Pharmaceuticals Acquires Exclusive Rights to EpiPen® in Canada

Products

In Canada, our leading brands include EpiPen® ,  Cytomel®, and Bicillin® L-A.

King provides access to basic information on our products as approved by Health Canada to healthcare professionals and patients with prescriptions. Canadian regulations limit the scope of information pharmaceutical companies can provide via the Internet and other media. If you require more detailed information, please contact your physician, pharmacist or other qualified healthcare professional. The information in this section is intended only for residents of Canada.

Leading Brands

  • EpiPen®
  • Cytomel®
  • Bicillin® L-A

Please visit the King Pharmaceuticals, Inc. U.S. website for an overview of King's comprehensive product portfolio in the U.S.

EpiPen® and EpiPen® Jr are registered trademarks of Mylan Inc. licensed exclusively to its wholly-owned subsidiary, Dey Pharma, L.P. of Basking Ridge, New Jersey, USA.

Cytomel is a registered trade mark of King Pharmaceuticals Research and Development, Inc. a wholly owned subsidiary of King Pharmaceuticals, Inc.

Bicillin is a registered trade mark of King Pharmaceuticals Research and Development, Inc. a wholly owned subsidiary of King Pharmaceuticals, Inc.

  • Home
  • About Us
  • Products
  • Newsroom
  • Business Development
  • Contact Us
  • Site Map
  • Legal
  • King Pharmaceuticals, Inc.

©2011 King Pharmaceuticals,® Inc. All rights reserved.

 

King Pharmaceuticals is now part of Pfizer Inc. The integration of King and Pfizer entities may be pending in various local jurisdictions and integration may be subject to completion of various local legal and regulatory obligations. All content in this message is subject to works council and/or union consultations, if applicable, and other legal requirements where appropriate.